Hartman Institute for Therapeutic Organ Regeneration

Suppression of tumor angiogenesis by Galpha(13) haploinsufficiency.

TitleSuppression of tumor angiogenesis by Galpha(13) haploinsufficiency.
Publication TypeJournal Article
Year of Publication2009
AuthorsChen L, J Zhang J, Rafii S, Huang X-Y
JournalJ Biol Chem
Volume284
Issue40
Pagination27409-15
Date Published2009 Oct 02
ISSN1083-351X
KeywordsAnimals, Antineoplastic Agents, Bone Marrow, Capillaries, Cell Line, Cell Movement, Corpus Luteum, Down-Regulation, Drug Discovery, Endothelial Cells, Female, GTP-Binding Protein alpha Subunits, G12-G13, Humans, Mice, Mutation, Neoplasm Transplantation, Neoplasms, Neovascularization, Pathologic, Ovarian Follicle, Reproduction, RNA Interference, Transplantation, Homologous, Vascular Endothelial Growth Factor A
Abstract

<p>Heterotrimeric G proteins are critical transducers of cellular signaling. Of the four families of G proteins, the physiological function of Galpha(13) is less well understood. Galpha(13) gene-deleted mice die at embryonic day approximately 9.5. Here, we show that heterozygous Galpha(13)(+/-) mice display defects in adult angiogenesis. Female Galpha(13)(+/-) mice showed a higher number of immature follicles and a lower density of blood vessels in the mature corpus luteum compared with Galpha(13)(+/+) mice. Furthermore, implanted tumors grew slower in Galpha(13)(+/-) host mice. These tumor tissues had many fewer blood vessels compared with those from Galpha(13)(+/+) host mice. Moreover, bone marrow-derived progenitor cells from Galpha(13)(+/+) mice rescued the failed growth of allografted tumors when reconstituted into irradiated Galpha(13)(+/-) mice. Hence, Galpha(13) is haploinsufficient for adult angiogenesis in both the female reproductive system and tumor angiogenesis.</p>

DOI10.1074/jbc.M109.025460
Alternate JournalJ Biol Chem
PubMed ID19654325
PubMed Central IDPMC2785670
Grant ListR01 HL091525 / HL / NHLBI NIH HHS / United States
R01 HL091525-02 / HL / NHLBI NIH HHS / United States
HL91525 / HL / NHLBI NIH HHS / United States

Weill Cornell Medicine
Hartman Institute for Therapeutic Organ Regeneration
1300 York Ave, Box 136 New York, NY 10065